How Continuous Manufacturing Is Transforming Oral Solid Dose Production

In this video from Virtual Pharma Expo February 2022, Alex Trombley of Syntegon presents how continuous manufacturing is changing oral solid dosage (OSD) production. Higher flexibility, shorter development times with minimum API usage, and a direct transfer from development to production without scale-up are among the primary requirements of pharmaceutical manufacturers. In continuous manufacturing, the processes occur one after the other without interruption while the product is charged and discharged simultaneously.

Virtual Pharma Expo is a unique event that features live equipment and technology presentations for both the OSD and Aseptic manufacturing industries.  This event is sponsored by Pharmaceutical Online, Federal Equipment and Techceuticals.